Experts point out regulatory and operational bottlenecks that challenge the consolidation of the national market, even after the advances of RDC 660/2022

Follow the instructions to initiate the import process through RDC 660

New resolution allows planting by universities and pharmaceutical industries, requiring maximum security systems and total traceability of the plant

The Sechat Portal spoke with Courier Brasil Express to address the main questions patients have regarding the importation of medications.

Proposal authorizes companies to cultivate plants with up to 0.3% THC exclusively for the production of medicinal inputs, but experts warn of the technical unfeasibility of the limit in a tropical climate

Anvisa points out the USA as the main supplier, followed by Canada, Colombia, and Uruguay

In an interview with the CB.Poder program of Correio Brasiliense, conducted by journalists Adriana Bernardes and Sibele Negromonte, Leandro Safatle, acting CEO of Anvisa, detailed the behind-the-scenes and expectations regarding the new regulation of medicinal cannabis and research in Brazil

Director of Institutional Relations evaluates national cultivation, new RDCs from Anvisa, and the challenges to consolidate the sector in the country

D9Tech establishes itself as the technological infrastructure driving the growth of the medical cannabis market in Brazil, offering integrated solutions in management, payments, and health with a focus on efficiency, security, and governance

The agency determined the suspension of the commercialization and advertising of all items from the brands Golden CBD Plus and Golden CBD+ Nanotech in the national territory.

Discover in Sechat 2024's free e-book how medical cannabis is revolutionizing dentistry, offering pain relief, inflammation control, and well-being during treatments.

With Anvisa's regulation, the use of medical cannabis for animals is starting to gain traction, benefiting the pet sector, veterinary medicine, and the medical cannabis market.

Understand the positioning of the legislation and the Federal Council of Physiotherapy regarding the role of physiotherapists in prescribing medicinal cannabis, as well as the challenges faced in practice.

Judge Vera Lúcia Feil's injunction orders the release of the company's cannabidiol after facing automatic denials from the regulatory agency

The municipality of Minas Gerais will acquire, through electronic bidding, cannabis-based medication to treat a patient with a rare genetic syndrome.

Imported product with medical prescription and authorization from Anvisa is being held by Federal Revenue at Gollog cargo terminal in Guarulhos

Companies report delays in the release of shipments, while official data from Anvisa indicates reduced average timelines and a high approval rate

Discover what medical cannabis is, what it is used for, and how this treatment has advanced in Brazil, with proven benefits and safe medical guidance.

New US rule restricts hemp derivatives and opens opportunity for South American countries to meet part of the Brazilian demand

End of the Farm Bill shutdown in the US exposes Brazil's vulnerability due to lack of cultivation and lack of productive autonomy to ensure self-sufficiency